lilin Tong
@lilin_tong
MS4 @BUSM | Aspiring hematologist-oncologist | Passionate about intersection of health equity and innovation | Often surfing, running, cooking, singing
Thrilled to share that I’ve matched at Brigham and Women’s for internal medicine! I’m still pinching myself! Grateful to the family, friends, and mentors who lifted me up along the way — I am standing on shoulders of giants. @BrighamMedRes @BUMedicine


The #EQUAL Study: "EGFR CtDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations" is open to enrollment! Learn more about it here: ⏬️⏬️ clinicaltrials.gov/study/NCT06716… @Florez_Lab @NarjustFlorezMD @lilin_tong @DanaFarberNews
Our #EQUAL study is FINALLY open! Listen in as @NarjustFlorezMD breaks down who can participate. Excited to share these news with you all!!!
📢 Meet Dr. Florez @NarjustFlorezMD, the Principal Investigator of the #EQUALstudy, as she shares more about this exciting research EN ESPAÑOL✨ #latinasinmed 🧬 This study uses a blood test to help detect EGFR+ lung cancer and we’re proud to offer participation in this study…
🎉 Big news our #equalstudy is officially OPEN! 🧬 Hear from our ctDNA Program Manager, Courtney Mantz, as she introduces this groundbreaking study using a simple blood test to possibly detect EGFR+ lung cancer. 👥 Are you 40+ and identify as Hispanic/Latinx or East/Southeast…
We’re recruiting! If you’re East Asian or Latinx and between 40–80 years old, you may be eligible to join our study on early lung cancer screening. Reach out to learn more. #equalstudy
Our EQUAL study is open to enrollment!! @EGFRResisters @EgfrUk @DFEGFRcenter @DFarberThoracic @Florez_Lab clinicaltrials.gov/study/NCT06716…
Getting great questions from patients with EGFR+ lung cancer about the #MARIPOSA and #MARIPOSA2 studies after #ELCC25, and how they differ. What else should we add to this table to make it more helpful? @EGFRResisters @jillfeldman4
With some many conversations about lung cancer in young women, I invite you revisit our editorial in @ASCO Connections early this year where we discussed the #HearHer campaign connection.asco.org/do/hearher-cam…
The sweetest gift from my ladies at @Florez_Lab to celebrate my match! Grateful to be surrounded by brilliant women who inspire me each day to break down barriers in cancer care. @NarjustFlorezMD #GreatWomenOfScience

The Florez Lab is hiring! Regulatory specialist and research data specialist for our New Clinical and Research Young Lung Cancer Program at Dana-Farber Cancer Institute Job posting here: careers.dana-farber.org/job/11220/rese… Please apply directly, no DMs.
What a day—found out I matched and was selected as a Massachusetts Medical Society 2025 Scholar! Incredibly grateful for the support and mentorship that got me where I am today. I am going to be a doctor!!
I am excited to share a blog I wrote for @cure_today highlighting the #LungCancerGeneticsStudy—a collaboration between the #lungcancer community and @23andMe to find the genetic risks of lung cancer. My kids are my personal why but the study represents something bigger:…
Grateful to work with these incredible women!!
The @florezlab has been #official for years but now we have the pictures to prove it! Our lab members had fun dressing up with our #merch and taking pretty pictures. Now there is concrete evidence we can be serious, fun and absolutely stunning at a second's notice. #pictureday
We were just notified all @NIH @NCICTEP_ClinRes @NCI meetings are now CANCELLED. Investigators PLS continue your hard work and dedication to make a difference. #Cancer is indifferent to politics and impacts everyone. @asco #ASCOGI25 #CancerResearch science.org/content/articl…
One of the best things we have done at the @Florez_Lab has been the #HearHer campaign to increase awareness about lung cancer in women ❤️
As #HearHer goes global, we’re excited to highlight some of the many amazing organizations standing with us.Their support has been crucial in expanding our reach and impact, while the invaluable resources they provide make a real difference for those affected by lung cancer.
A must-read Review on the ever-evolving field of #EGFR mut #NSCLC in@NatRevClinOncol highlighting: ➡️Strategies to improve on 1L 3rd Gen TKI mono therapy ➡️ Ways to tackle resistance post-Osi ➡️Perioperative landscape @LeXiuning @danieltanmd @RamalingamMD @IASLC #LCSM #some